Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 36 (December 20), 2005: pp. 9344-9350
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.03.5915

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soliman, P. T.
Right arrow Articles by Lu, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soliman, P. T.
Right arrow Articles by Lu, K. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Women With Synchronous Primary Cancers of the Endometrium and Ovary: Do They Have Lynch Syndrome?

Pamela T. Soliman, Russell R. Broaddus, Kathleen M. Schmeler, Molly S. Daniels, Delia Gonzalez, Brian M. Slomovitz, David M. Gershenson, Karen H. Lu

From the Departments of Gynecologic Oncology, Pathology, and Clinical Cancer Genetics, the University of Texas M.D. Anderson Cancer Center, Houston, TX

Address reprint requests to Karen H. Lu, MD, Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, 1155 Herman P. Pressler St, CPB 6.3244, Unit 1362, Houston, TX 77030; e-mail: khlu{at}mdanderson.org

PURPOSE: Lynch syndrome (hereditary nonpolyposis colorectal cancer; HNPCC) is an autosomal-dominant cancer predisposition syndrome that increases risk for multiple cancers, including colon, endometrial, and ovarian cancer. Revised Bethesda Criteria recommend that patients with two HNPCC-associated cancers undergo molecular evaluation to determine whether they have a mismatch repair (MMR) defect associated with HNPCC. The purpose of our study was to determine the likelihood of MMR defects (MSH2, MSH6, MLH1) in women with synchronous endometrial and ovarian cancer.

PATIENTS AND METHODS: Between 1989 and 2004, 102 women with synchronous endometrial and ovarian cancers were identified; 59 patients had tumor blocks available for analysis. Patients were divided into risk groups based on family history: high (met Amsterdam criteria), medium (personal history or first-degree relative with an HNPCC-associated cancer), and low (all others). Protein expression for MSH2, MSH6, and MLH1 was evaluated by immunohistochemistry. Microsatellite instability and MLH1 promoter methylation analyses were performed on a subset of cases.

RESULTS: Median age was 50 years. Two patients met Amsterdam criteria for HNPCC. Five additional patients, all medium-risk, had molecular findings consistent with a germline mutation of either MSH2 or MLH1. None of the low-risk patients had molecular results consistent with a germline mutation.

CONCLUSION: Overall, 7% of women in our cohort met either clinical or molecular criteria for Lynch syndrome. All of these women had a prior history or a first-degree relative with an HNPCC-associated cancer. Limiting genetic evaluation to women with synchronous endometrial and ovarian cancer who have a family history suggestive of HNPCC may appropriately identify women with Lynch syndrome.

Supported by National Institutes of Health Grant No. N01-CN-05127 (Chemoprevention of Endometrial Cancer in Hereditary Nonpolyposis Colorectal Cancer) and 1P50CA098258-01 (Specialized Program of Research Excellence in Uterine Cancer).

Presented at the Annual Meeting for The Society of Gynecologic Oncologists, Miami, FL, March 19-23, 2005.

Authors’ disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
K Garg and R A Soslow
Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma
J. Clin. Pathol., August 1, 2009; 62(8): 679 - 684.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
K. H. Lu, J. O. Schorge, K. J. Rodabaugh, M. S. Daniels, C. C. Sun, P. T. Soliman, K. G. White, R. Luthra, D. M. Gershenson, and R. R. Broaddus
Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer
J. Clin. Oncol., November 20, 2007; 25(33): 5158 - 5164.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online